Loading data for NDRA — first visit, this takes a few seconds.
ENDRA Life Sciences Inc. (NDRA)
NasdaqCM: NDRA
· Real-Time Price · USD
5.00
-0.41 (-7.58%)
At close: Aug 28, 2026, 3:59 PM
5.11
+2.10%
After-hours: 5:42 PM
The price, the headline numbers and the latest news, in one place.
ENDRA Life Sciences Inc. (NDRA) Stock Price, Analysis & Data
-7.58% (1D)
| Bid | 4.1 |
| Market Cap | 7.51M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -5.92M |
| -0.07 | |
| -6.29 | |
| n/a | |
| -1.65 | |
| P/B (ttm) | 1.19 |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | 6.88 |
| Volume | 24,371 |
| Avg. Volume (20D) | 30,626 |
| Open | 5.74 |
| Previous Close | 5.41 |
| Day's Range | 5.00 - 5.74 |
| 52-Week Range | 2.96 - 9.85 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About NDRA
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition...
Industry Diagnostics & Research
Sector Healthcare
IPO Date Jun 30, 2017
Employees 9
Stock Exchange NasdaqCM
Ticker Symbol NDRA
Website https://endrainc.com
Financial Performance
In 2025, ENDRA Life Sciences's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -7.03M, a decrease of -38.93%.
Financial Statements
Page 1 of 2